Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future

Citations

WEB OF SCIENCE

23
Citations

SCOPUS

25

초록

Hepatocellular carcinomas (HCCs) frequently recur despite initial successful surgical resection or local ablation therapy. Diagnostic methods for small HCCs have improved with the introduction of gadoxetic acid-enhanced liver magnetic resonance imaging and diffusion-weighted imaging (DWI). Currently, sub-centimeter recurrent nodules showing typical hallmark imaging findings of HCC are frequently detected in patients with a treatment history for HCC. With five typical magnetic resonance findings, including arterial enhancement, washout on portal or transitional phase, high signal intensity on both T2-weighted image and DWI, and low signal intensity on hepatobiliary phase, sub-centimeter recurrent HCC can be diagnosed with high accuracy. Although more information is needed to determine the treatment of choice, local ablation therapy under fusion imaging and/or contrast-enhanced ultrasound guidance or cone-beam computed tomography-guided chemoembolization seem to be promising as they are effective and safe for the management of sub-centimeter recurrent HCCs.

키워드

Hepatocellular carcinoma; Recurrence; Sub-centimeter; Ablation; Diagnosis; PERCUTANEOUS RADIOFREQUENCY ABLATION; ACID-ENHANCED MRI; CLINICAL-PRACTICE GUIDELINES; DIAGNOSTIC PERFORMANCE; SURGICAL RESECTION; LI-RADS; 1 CM; CT; FUSION; US
제목
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
저자
Lee, Min Woo; Lim, Hyo Keun
DOI
10.3748/wjg.v24.i46.5215
발행일
2018-12-14
유형
Review
저널명
World Journal of Gastroenterology
권
24
호
46
페이지
5215 ~ 5222